摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-氰基环丁烷羧酸甲酯 | 58920-79-9

中文名称
1-氰基环丁烷羧酸甲酯
中文别名
——
英文名称
methyl 1-cyanocyclobutanecarboxylate
英文别名
1-Cyan-1-methoxycarbonyl-cyclobutan;1-cyano-cyclobutanecarboxylic acid methyl ester;1-cyano-cyclobutyl-carboxylic acid methyl ester;methyl 1-cyanocyclobutane-1-carboxylate
1-氰基环丁烷羧酸甲酯化学式
CAS
58920-79-9
化学式
C7H9NO2
mdl
MFCD10758063
分子量
139.154
InChiKey
WCTZTNWBOZFXTE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    225.7±23.0 °C(Predicted)
  • 密度:
    1.12±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.714
  • 拓扑面积:
    50.1
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2926909090
  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    室温且干燥

SDS

SDS:98b00e30c18f16a4ed14450382e3c800
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-氰基环丁烷羧酸甲酯硼烷四氢呋喃络合物potassium carbonate 作用下, 以 四氢呋喃甲醇乙腈 为溶剂, 反应 136.0h, 生成 6-carboxymethyl-3-{{[1-(N,N-dicarboxymethyl)-2-aminomethyl]-cyclobut-1-yl}methyl}-3,6-diazaoctanedioic acid
    参考文献:
    名称:
    Ligand and metal complex
    摘要:
    提供了一种Formula (I)的配体: 其中A4代表氢原子、硝基、氨基、硫氰基或—Z—Y,其中Z是二价连接基团,Y是源自生物相容分子的基团,但当X为亚甲基时,A4不能是氢原子或硝基。还提供了具有该配体的金属配合物,可用作血池造影剂或靶向造影剂。
    公开号:
    US20110065905A1
  • 作为产物:
    描述:
    1,3-二溴丙烷氰乙酸甲酯1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以62.85%的产率得到1-氰基环丁烷羧酸甲酯
    参考文献:
    名称:
    Ligand and metal complex
    摘要:
    提供了一种Formula (I)的配体: 其中A4代表氢原子、硝基、氨基、硫氰基或—Z—Y,其中Z是二价连接基团,Y是源自生物相容分子的基团,但当X为亚甲基时,A4不能是氢原子或硝基。还提供了具有该配体的金属配合物,可用作血池造影剂或靶向造影剂。
    公开号:
    US20110065905A1
  • 作为试剂:
    描述:
    氰乙酸甲酯1,8-二氮杂双环[5.4.0]十一碳-7-烯1,3-二溴丙烷 、 、 、 、 在 氮气氯仿1-氰基环丁烷羧酸甲酯 、 SiO2 、 acetone hexane 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 1.17h, 以yielding 8.74 g (62.81%)的产率得到1-氰基环丁烷羧酸甲酯
    参考文献:
    名称:
    Cycloalkyl triamine pentacarboxylate as ligands for paramagnetic metal complexes
    摘要:
    提供了一种环状烷基三胺五羧酸化合物,它与金属离子配位形成高稳定性金属配合物在血清中。本发明的金属配合物可用作磁共振成像(MRI)的对比剂。
    公开号:
    US08877163B2
点击查看最新优质反应信息

文献信息

  • Efficient Decarboxylative/Defluorinative Alkylation for the Synthesis of <scp> <i>gem</i> ‐Difluoroalkenes </scp> through an <scp> S <sub>N</sub> 2 </scp> ’‐Type Route
    作者:Wei‐Long Xing、Jia‐Xin Wang、Ming‐Chen Fu、Yao Fu
    DOI:10.1002/cjoc.202100709
    日期:2022.2
    An efficient decarboxylative/defluorinative alkylation for synthesizing gem-difluoroalkenes is described, providing a general method for installation of the challenging alkyl fragments containing α-electron-withdrawing groups into α-trifluoromethyl alkenes. Mechanistic studies suggest that this process involves an SN2′-type synthetic route in the absence of transition-metal catalysts or photocatalysis
    描述了一种用于合成偕二氟烯烃的有效脱羧/脱氟烷基化反应,为将含有 α-吸电子基团的具有挑战性的烷基片段安装到 α-三氟甲基烯烃中提供了一种通用方法。机理研究表明,该过程涉及在没有过渡金属催化剂或光催化的情况下的 S N 2' 型合成路线。此外,该协议可以很容易地扩大规模,并成功应用于生物活性分子的修饰,从而补充了获得结构通用的gem-二氟烯烃的方法。
  • 含双并环类衍生物、其制备方法和应用
    申请人:上海翰森生物医药科技有限公司
    公开号:CN116444493A
    公开(公告)日:2023-07-18
    本发明涉及含双并环类衍生物、其制备方法和应用。特别地,本发明涉及通式(I)所示的化合物、其制备方法及含有该化合物的药物组合物,及其作为生物调节剂在制备治疗自身免疫疾病、慢性炎性疾病、急性炎症性疾病、自身炎性疾病、动脉粥样硬化、糖尿病、纤维变性疾病、代谢疾病、癌症、肿瘤、白血病和淋巴瘤的药物中的应用,其中通式(I)中的各取代基与说明书中的定义相同。
  • Synthesis and Physicochemical Characterization of Carbon Backbone Modified [Gd(TTDA)(H<sub>2</sub>O)]<sup>2−</sup> Derivatives
    作者:Ya-Hui Chang、Chiao-Yun Chen、Gyan Singh、Hsing-Yin Chen、Gin-Chung Liu、Yih-Gang Goan、Silvio Aime、Yun-Ming Wang
    DOI:10.1021/ic101799c
    日期:2011.2.21
    The present study was designed to exploit optimum lipophilicity and high water-exchange rate (k(ex)) on low molecular weight Gd(III) complexs to generate high bound relaxivity (r(1)(b)), upon binding to the lipophilic site of human serum albumin (HSA). Two new carbon backbone modified TTDA (3,6,10-tri(carboxymethyl)-3,6,10-triazadodecanedioic acid) derivatives, CB-TTDA and Bz-CB-TTDA, were synthesized. The complexes [Gd(CB-TTDA)(H2O)](2-) and [Gd(Bz-CB-TTDA)(H2O)](2-) both display high stability constant (log K-GdL = 20.28 and 20.09, respectively). Furthermore, CB-TTDA (log K-(Gd/Zn) = 4.22) and Bz-CB-TTDA (log K-(Gd/Zn) = 4.12) exhibit superior selectivity of Gd(III) against Zn(II) than those of TTDA (log K-(Gd/Zn) = 2.93), EPTPA-bz-NO2 (log K-(Gd/Zn) = 3.19), and DTPA (log K-(Gd/Zn) = 3.76). However, the stability constant values of [Gd(CB-TTDA)(H2O)](2-) and [Gd(Bz-CB-TTDA)(H2O)](2-) are lower than that of MS-325. The parameters that affect proton relaxivity have been determined in a combined variable temperature O-17 NMR and NMRD study. The water exchange rates are comparable for the two complexes, 232 x 10(6) s(-1) for [Gd(CB-TTDA)(H2O)](2-) and 271 x 10(6) s(-1) for [Gd(Bz-CB-TTDA)(H2O)](2-). They are higher than those of [Gd(TTDA)(H2O)](2-) (146 x 10(6) s(-1)), [Gd(DTPA)(H2O)](2-) (4.1 x 10(6) s(-1)), and MS-325 (6.1 x 10(6) s(-1)). Elevated stability and water exchange rate indicate that the presence of cyclobutyl on the carbon backbone imparts rigidity and steric constraint to [Gd(CB-TTDA)(H2O)](2-) and [Gd(Bz-CB-TTDA)(H2O)](2-). In addition, the major objective for selecting the cyclobutyl is to tune the lipophilicity of [Gd(Bz-CB-TTDA)(H2O)](2-). The binding affinity of [Gd(Bz-CB-TTDA)(H2O)](2-) to HSA was evaluated by ultrafiltration study across a membrane with a 30 kDa MW cutoff, and the first three stepwise binding constants were determined by fitting the data to a stoichiometric model. The binding association constants (K-A) for [Gd(CB-TTDA)(H2O)](2-) and [Gd(Bz-CB-TTDA)(H2O)](2-) are 1.1 x 10(2) and 1.5 x 10(3), respectively. Although the K-A value for [Gd(Bz-CB-TTDA)(H2O)](2-) is lower than that of MS-325 (K-A = 3.0 x 10(4)), the r(1)(b) value, r(1)(b) = 66.7 mM(-1) s(-1) for [Gd(Bz-CB-TTDA)(H2O)](2-), is significantly higher than that of MS-325 (r(1)(b) = 47.0 mM(-1) s(-1)). As measured by the Zn(II) transmetalation process, the kinetic stabilities of [Gd(CB-TTDA)(H2O)](2-), [Gd(Bz-CB-TTDA)(H2O)](2-), and [Gd(DTPA)(H2O)](2-) are similar and are significantly higher than that of [Gd(DTPA-BMA)(H2O)](2-) High thermodynamic and kinetic stability and optimized lipophilicity of [Gd(CB-TTDA)(H2O)](2-) make it a favorable blood pool contrast agent for MRI.
  • Preparation and Structure ofβ-Peptides Consisting of Geminally Disubstitutedβ2,2- andβ3,3-Amino Acids: A Turn Motif forβ-Peptides
    作者:Dieter Seebach、Stefan Abele、Thierry Sifferlen、Martin Hänggi、Sibylle Gruner、Paul Seiler
    DOI:10.1002/(sici)1522-2675(19981216)81:12<2218::aid-hlca2218>3.0.co;2-0
    日期:1998.12.16
    We report on the synthesis of new and previously described beta-peptides (1-6), consisting of up to twelve beta(2,2-) or beta(3,3)-geminally disubstituted beta-amino acids which do not fit into any of the secondary structural patterns of beta-peptides, hitherto disclosed. The required 2,2- and 3,3-dimethyl derivatives of 3-aminopropanoic acid are readily obtained from 3-methylbut-2-enoic acid and ammonia (Scheme 1) and from Boc-protected methyl 3-aminopropanoate by enolate methylation (Scheme 2). Protected (Boc for solution-, Fmoc for solid-phase syntheses) 1-(aminomethyl)cycloalkanecarboxylic-acid derivatives (with cyclopropane, cyclobutane, cyclopentane, and cyclohexane rings) are obtained from 1-cyanocycloalkanecarboxylates and the corresponding dihaloalkanes (Scheme 3). Fully C-13- and N-15-labeled 3-amino-2,2-dimethylpropanoic-acid derivatives were prepared from the corresponding labeled precursors (see asterixed formula numbers and Scheme 4). Coupling of these amino acids was achieved by methods which we had previously employed for other beta-peptide syntheses ( intermediates 18 - 23). Crystal structures of Boc-protected geminally disubstituted amine acids (16a-d) and of the corresponding tripeptide (23a), as well as NMR and IR spectra of an isotopically labeled beta-hexapeptide (2a*) are presented (Figs. 1-4) and discussed. The tripeptide structure contains a ten-membered H-bonded ring which is proposed to be a turn-forming motif for beta-peptides (Fig. 2).
  • Oediger,H.; Moeller,F., Justus Liebigs Annalen der Chemie, 1976, p. 348 - 351
    作者:Oediger,H.、Moeller,F.
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物